Join Professor Ed Vital, an Honorary Consultant Rheumatologist, at Leeds Teaching Hospitals NHS Trust in the UK and Professor Eric Morand, Dean of the Sub-Faculty of Clinical and Molecular Medicine at Monash University, and Head of Rheumatology at Monash Health, in Melbourne Australia, as they discuss Professor Morand’s recent paper ‘Enpatoran, a toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: Findings from cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding Phase 2 trial.’